symmetric dimethylarginine has been researched along with Fibrosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Huang, D; Lin, P; Tan, B; Wang, Y; Wu, M; Ye, C | 1 |
| Atzler, D; Böger, RH; Chen, P; Chen, Y; Fassett, J; Guo, H; Hu, X; Kwak, D; Liu, X; Lu, Z; Schwedhelm, E; Wang, H; Xu, X; Yue, W; Zhang, P | 1 |
| Kokot, F; Kunsdorf-Wnuk, A; Wnuk, Z | 1 |
3 other study(ies) available for symmetric dimethylarginine and Fibrosis
| Article | Year |
|---|---|
SDMA attenuates renal tubulointerstitial fibrosis through inhibition of STAT4.
Topics: Animals; Chromatography, Liquid; Fibrosis; Humans; Kidney; Kidney Diseases; Mice; Renal Insufficiency, Chronic; RNA, Small Interfering; STAT4 Transcription Factor; Tandem Mass Spectrometry; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ureteral Obstruction | 2023 |
Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction.
Topics: Amidohydrolases; Animals; Arginine; Atrial Natriuretic Factor; Disease Models, Animal; Fibrosis; Genetic Predisposition to Disease; Hypertrophy, Left Ventricular; Male; Mice, Knockout; Myocytes, Cardiac; Nitric Oxide; Phenotype; Signal Transduction; Tyrosine; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2017 |
Diagnostic value of plasma asymmetric and symmetric dimethylarginine levels in liver transplant recipients.
Topics: Alanine Transaminase; Arginine; Aspartate Aminotransferases; Biomarkers; Cadaver; Fibrosis; Humans; Kidney Transplantation; Predictive Value of Tests; Renal Insufficiency, Chronic | 2012 |